Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections
Condition(s):PainLast Updated:April 4, 2018Completed
Hide Studies Not Open or Pending
Condition(s):PainLast Updated:April 4, 2018Completed
Condition(s):CataractLast Updated:March 7, 2017Completed
Condition(s):PainLast Updated:May 5, 2017Completed
Condition(s):Intraocular PressureLast Updated:November 27, 2013Completed
Condition(s):CataractLast Updated:December 17, 2012Completed
Condition(s):Diabetic Macular EdemaLast Updated:May 13, 2015Completed
Condition(s):Macular Thickening; Macular EdemaLast Updated:December 4, 2008Unknown status
Condition(s):Diabetic Macular EdemaLast Updated:March 20, 2018Completed
Condition(s):Non-Proliferative Diabetic Retinopathy; CataractLast Updated:August 3, 2016Completed
Condition(s):Uveitis; Macular EdemaLast Updated:January 13, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.